APA

Wei S., Liu M., Tsai Y., Liao C., Chen C., Wang W., Huang Y., Chang F. & Chou P. (20151104). The safety and immunogenicity of a MF59-adjuvanted H5N1 prepandemic influenza vaccine in healthy adults primed with homologous or heterologous H5N1 vaccines: an observational study. : BMC infectious diseases.

Chicago

Wei Sung-Hsi, Liu Ming-Tsan, Tsai Yao-Chou, Liao Chung-Hsin, Chen Chih-Ming, Wang Wei-Yao, Huang Yi-Lung, Chang Feng-Yee and Chou Pesus. 20151104. The safety and immunogenicity of a MF59-adjuvanted H5N1 prepandemic influenza vaccine in healthy adults primed with homologous or heterologous H5N1 vaccines: an observational study. : BMC infectious diseases.

Harvard

Wei S., Liu M., Tsai Y., Liao C., Chen C., Wang W., Huang Y., Chang F. and Chou P. (20151104). The safety and immunogenicity of a MF59-adjuvanted H5N1 prepandemic influenza vaccine in healthy adults primed with homologous or heterologous H5N1 vaccines: an observational study. : BMC infectious diseases.

MLA

Wei Sung-Hsi, Liu Ming-Tsan, Tsai Yao-Chou, Liao Chung-Hsin, Chen Chih-Ming, Wang Wei-Yao, Huang Yi-Lung, Chang Feng-Yee and Chou Pesus. The safety and immunogenicity of a MF59-adjuvanted H5N1 prepandemic influenza vaccine in healthy adults primed with homologous or heterologous H5N1 vaccines: an observational study. : BMC infectious diseases. 20151104.